SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...
More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...
Children’s Health Ireland (CHI) has issued a ‘sincere apology’ for shortcomings in the care of a Dublin teenager who died following a severe asthma attack while waiting over four years to see a ...
As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...
A new bronchodilator delivery device, SOBIstat-F, reduced hospitalization rates and improved clinical outcomes in children with severe acute asthma, according to a randomized clinical trial presented ...
What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...
An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. The drug dupilumab (Dupixent) effectively clears up airways ...
The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but rejected its use for another condition, the drugmaker said on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback